A detailed history of Graham Capital Management, L.P. transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 29,682 shares of KOD stock, worth $80,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,682
Holding current value
$80,438
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.29 - $4.48 $67,971 - $132,975
29,682 New
29,682 $69,000
Q4 2023

Feb 14, 2024

BUY
$1.4 - $3.24 $20,066 - $46,438
14,333 New
14,333 $43,000
Q2 2023

Aug 14, 2023

BUY
$4.3 - $9.48 $57,736 - $127,287
13,427 New
13,427 $92,000
Q3 2022

Nov 14, 2022

BUY
$7.57 - $12.5 $462,103 - $763,050
61,044 Added 109.18%
116,953 $905,000
Q2 2022

Aug 15, 2022

SELL
$5.04 - $9.48 $1.21 Million - $2.27 Million
-239,761 Reduced 81.09%
55,909 $427,000
Q1 2022

May 16, 2022

BUY
$7.09 - $89.45 $2.1 Million - $26.4 Million
295,670 New
295,670 $2.28 Million

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $141M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.